latest news releases from the newsroom
HEAD NV Announces the Delisting of Its Ordinary Shares From the NYSE
AMSTERDAM, Netherlands, April 1, 2008 (PRIME NEWSWIRE) -- Head N.V. (VSX:HEAD), a leading global manufacturer and marketer of sports equipment, announced today the delisting of its ordinary shares from the New York Stock Exchange (NYSE). Following the press release on the 10th March announcing its intention to delist, Head NV filed a Form 25 with the Securities and Exchange Commission (SEC) on the 21st March 2008 and the delisting became effective on the 31st March 2008.
Epigenomics and TIB MOLBIOL Launch First in a Series of Products At Analytica 2008
BERLIN and SEATTLE, April 1, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECS) (Prime Standard), a molecular diagnostics company developing products based on DNA methylation analysis, together with TIB MOLBIOL GmbH (Berlin/Germany) today launched the first in a series of research products at Analytica 2008, the leading industry trade fair in Munich. The products include real-time PCR kits for Epigenomics' proprietary biomarkers and reference assay kits produced under the brand name LightMix(r) by TIB MOLBIOL under license from Epigenomics. Further, the products launched include DNA methylation quantification standards produced by Epigenomics. Initially, Epigenomics will be the sole distributor of the product line in Europe and other regions excluding the U.S.